Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
05 2019
Historique:
received: 28 11 2018
accepted: 04 02 2019
pubmed: 23 2 2019
medline: 16 7 2020
entrez: 22 2 2019
Statut: epublish

Résumé

A mass spectrometry (MS) method that detects a serum disaccharide (DS) (MS-DS) was recently described for the diagnosis of invasive fungal infections (IFI). We carried out a European collaborative study to evaluate this assay. Patients with the following IFI were selected according to the availability of sera obtained at about the time that IFI was documented: invasive candidiasis (IC;

Identifiants

pubmed: 30787140
pii: JCM.01867-18
doi: 10.1128/JCM.01867-18
pmc: PMC6498025
pii:
doi:

Substances chimiques

Antigens, Fungal 0
Disaccharides 0
Mannans 0
galactomannan 11078-30-1
Galactose X2RN3Q8DNE

Types de publication

Evaluation Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 Cornu et al.

Références

Clin Microbiol Infect. 2012 Dec;18 Suppl 7:53-67
pubmed: 23137137
Clin Microbiol Infect. 2015 Jan;21(1):88.e1-6
pubmed: 25636941
Biol Pharm Bull. 1993 Sep;16(9):822-8
pubmed: 8268846
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38
pubmed: 29544767
J Med Microbiol. 1988 Dec;27(4):239-45
pubmed: 3058980
Expert Rev Anti Infect Ther. 2014 Jul;12(7):731-4
pubmed: 24850393
Clin Infect Dis. 2016 Feb 15;62(4):e1-50
pubmed: 26679628
Clin Microbiol Infect. 2016 Sep;22(9):810.e1-810.e8
pubmed: 26706615
J Clin Microbiol. 2018 Mar 26;56(4):
pubmed: 29367293
Eur J Clin Microbiol Infect Dis. 2017 May;36(5):807-812
pubmed: 27987046
J Clin Microbiol. 2008 May;46(5):1647-54
pubmed: 18322056
J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i19-i28
pubmed: 28355464
Clin Infect Dis. 2012 Aug;55(4):521-6
pubmed: 22573851
Expert Rev Anti Infect Ther. 2011 Jul;9(7):881-92
pubmed: 21810058
Infect Dis Clin North Am. 2016 Dec;30(4):1023-1052
pubmed: 27816138
Methods Mol Biol. 2017;1508:3-15
pubmed: 27837496
Clin Microbiol Infect. 2014 Apr;20 Suppl 3:76-98
pubmed: 24102785
BMC Infect Dis. 2017 Apr 13;17(1):272
pubmed: 28407752
Crit Rev Microbiol. 2015 Jun;41(2):208-17
pubmed: 23962107
Semin Immunopathol. 2015 Mar;37(2):163-71
pubmed: 25404119
Lancet Infect Dis. 2017 Nov;17(11):e344-e356
pubmed: 28774702
J Clin Microbiol. 2016 Nov;54(11):2786-2797
pubmed: 27605710
Clin Infect Dis. 2013 May;56(10):e95-101
pubmed: 23420816
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60
pubmed: 27365388
Med Mycol. 1998 Oct;36(5):275-9
pubmed: 10075496
Clin Microbiol Infect. 2004 Mar;10 Suppl 1:48-66
pubmed: 14748802
J Antimicrob Chemother. 2018 Mar 1;73(suppl_4):iv2-iv5
pubmed: 29608754
J Infect Dis. 2015 Feb 1;211(3):445-51
pubmed: 25149761
Infect Immun. 1992 Jun;60(6):2237-45
pubmed: 1375195
Ann Lab Med. 2017 Nov;37(6):475-483
pubmed: 28840984
Clin Infect Dis. 2012 Mar 1;54(5):633-43
pubmed: 22198786
Virulence. 2017 Feb 17;8(2):143-149
pubmed: 27248439
Med Mycol. 2018 Apr 1;56(suppl_1):60-72
pubmed: 29087518
Clin Infect Dis. 2009 Apr 15;48(8):1042-51
pubmed: 19281327
N Engl J Med. 2015 Oct 8;373(15):1445-56
pubmed: 26444731
Clin Microbiol Infect. 2012 Apr;18(4):E99-E109
pubmed: 22329526
Clin Infect Dis. 2016 Nov 15;63(10):1312-1317
pubmed: 27535951
Semin Respir Crit Care Med. 2015 Oct;36(5):692-705
pubmed: 26398536
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
pubmed: 18462102
Nat Rev Microbiol. 2017 Nov;15(11):661-674
pubmed: 28919635

Auteurs

Marjorie Cornu (M)

Laboratoire de Parasitologie Mycologie, CHU Lille, Université Lille, INSERM U995-LIRIC (Lille Inflammation Research International Centre), Lille, France.

Boualem Sendid (B)

Laboratoire de Parasitologie Mycologie, CHU Lille, Université Lille, INSERM U995-LIRIC (Lille Inflammation Research International Centre), Lille, France boualem.sendid@univ-lille.fr daniel.poulain@univ-lille.fr.

Alexandre Mery (A)

Unité de Glycobiologie Structurale et Fonctionnelle UMR CNRS, Université de Lille 1, Villeneuve d'Ascq, France.

Nadine François (N)

Laboratoire de Parasitologie Mycologie, CHU Lille, Université Lille, INSERM U995-LIRIC (Lille Inflammation Research International Centre), Lille, France.

Malgorzata Mikulska (M)

Division of Infectious Disease, Ospedale Policlinico San Martino, Department of Health Sciences, University of Genoa, Genoa, Italy.

Valérie Letscher-Bru (V)

Institut de Parasitologie et de Pathologie Tropicale-Université de Strasbourg, Laboratoire de Mycologie Médicale, CHU de Strasbourg, Strasbourg, France.

Elena De Carolis (E)

Department of Laboratory Sciences and Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Lauro Damonti (L)

Service des Maladies Infectieuses, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Marie Titecat (M)

Laboratoire de Bactériologie CHU Lille, Université Lille, INSERM U995-LIRIC (Lille Inflammation Research International Centre), Lille, France.

Pierre-Yves Bochud (PY)

Service des Maladies Infectieuses, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Alexandre Alanio (A)

Institut Pasteur, Molecular Mycology Unit, Département de Mycologie, CNRS UMR2000, Paris, France.
Laboratoire de Parasitologie-Mycologie, Hôpital Saint-Louis, Groupe Hospitalier Lariboisière, Saint-Louis, Fernand Widal, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Maurizio Sanguinetti (M)

Department of Laboratory Sciences and Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Claudio Viscoli (C)

Division of Infectious Disease, Ospedale Policlinico San Martino, Department of Health Sciences, University of Genoa, Genoa, Italy.

Raoul Herbrecht (R)

Oncologie et Hématologie, INSERM, UMR-S1113/IRFAC, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, Strasbourg, France.

Yann Guerardel (Y)

Unité de Glycobiologie Structurale et Fonctionnelle UMR CNRS, Université de Lille 1, Villeneuve d'Ascq, France.

Daniel Poulain (D)

Laboratoire de Parasitologie Mycologie, CHU Lille, Université Lille, INSERM U995-LIRIC (Lille Inflammation Research International Centre), Lille, France boualem.sendid@univ-lille.fr daniel.poulain@univ-lille.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH